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LETTERS TO THE EDITORMINIMAL EXTRACORPOREAL
CIRCULATION ISA PROMISING
ALTERNATIVE FOR OFF-PUMP
REVASCULARIZATION IN
ADULTS
To the Editor:
We readwith great interest the article
by Formica and colleagues.1 They
report their results of a prospective,
randomized, single-center study on sys-
temic and myocardial inflammatory
responses, as well as the early clinical
outcome after off-pump and minimized
extracorporeal circulation (MECC)-
guided coronary bypass surgery. Sixty
patients were randomized: 30 patients
each in the MECC and off-pump sur-
gery groups. They found an increased
interleukin-6 plasma level 24 hours
after off-pump bypass surgery and
increased tumor necrosis factor-
a plasma level in both groups. Trans-
myocardial gradients did not differ
between the groups. With regard to the
clinical data, hemoglobin levels in the
MECC group were significantly higher
in comparison with the off-pump sur-
gery group 24 hours after the operation
(both groups received the same number
of packed red blood cells).
Our group recently investigated
1674 patients who underwent elective,
emergency bypass surgery with
standard extracorporeal circulation,
MECC, and off-pump surgery in
a 3-year period.2 Our results in terms
of creatinine kinase values and time
course were similar. In the postopera-
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in the off-pump coronary artery bypass
and MECC groups, whereas signifi-
cantly more packed red blood cells
were mandatory in the standard extra-
corporeal circulation group. Although
postoperative drainage loss was higher
in our analysis in theMECC group, the
same postoperative hemoglobin
values as in the off-pump group were
reached. Although a cell-saving device
was used in the MECC group, as well
as in the off-pump coronary artery
bypass and extracorporeal circulation
groups, this equal administration of
packed red blood cells in the MECC
and off-pump coronary artery bypass
groups is explained by the low priming
volume less than 500 mL in theMECC
group. As a further result of the good
biocompatibility of the MECC device,
the target activated clotting time is
adequate at a range of 200 to 300
seconds and therefore approximately
at the range in the off-pump procedure.
Another interesting finding in our
analysis for the MECC group was the
reduced incidence of cerebral acci-
dents compared with off-pump and
standard extracorporeal circulation
revascularization, although clampless
proximal anastomoses with the heart
string device were performed in the
off-pump group. This may be
explained by Liebold and colleagues,3
who described a better cerebral tissue
oxygenation and a lower rate of
microembolization during MECC
surgery.3 Furthermore, we could
improve the in-hospital mortality rate
in comparison with the off-pump and
standard extracorporeal circulation
procedures in the MECC group.
In conclusion, we agree with For-
mica and colleagues1 that MECC has
great potential in the future of coro-
nary bypass surgery. In our experi-
ence, MECC has the advantage of
easy, safe, and reproducible revascu-
larization with approximately the
same benefits as off-pump surgery.
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My coworkers and I appreciate
Puelher and colleagues’ comments,
and we are pleased that they agree
with the conclusions of our study.1 Dur-
ing recent years, there has been
increasing interest in the use of
miniaturized extracorporeal circulation
(MECC),with goodoutcomes reported.
Off-pump coronary artery bypass graft-
ing (CABG) has had a dramatic in-
crease during recent years because of
several advantages relative to standard
CABG with extracorporeal circulation
(ECC) in terms of reduced in-hospital
mortality and morbidity, reduced myo-
cardial damage, and better protection
of renal and pulmonary function.
Many surgeons recognize some limita-
tions of off-pump CABG, however,
such as incompletemyocardial revascu-
larization2,3 repeated revasculariza-
tion,4 and higher hospital costs.5
We think that a primary objective
during routine clinical activity is im-
provement of the technique of ECC
and the biocompatibility of the tubing
circuit to minimize systemic, cardiac
inflammatory, and neurologic damage.
ECC has improved through the years,ry c Volume 139, Number 1 233
Letters to the Editorand the constant improvements in re-
sults during the last 50 years are also
due to the different ECC techniques
that were developed during this long
period. At many institutions, off-
pump CABG represents about 20%
to 30% of cardiac surgical procedures.
The remainder of the operations are
performed with ECC. We, therefore,
believe that further improvement of
ECC could improve overall results.
In fact, according to our results1 and
the results of Puelher and colleagues,
with the MECC is possible to perform
a complete myocardial revasculariza-
tion with the same systemic, cardiac,
and clinic results observed with off-
pump CABG. Moreover, we think
that this system could be safely ex-
tended to other, more complex cardiac
operations, such as the Bentall opera-
tion, aortic valve replacement, ascend-
ing aortic replacement, and mitral
valve surgery.
Recently, we used the MECC in
the cases of 2 patients with a large
thrombus of the inferior vena cava as a
complication of a left renal tumor.
Urologists referred the patients to us,
and they preferred to perform the oper-
ation during a period of circulatory
arrest. We decide to use the MECC for
both patients, with the aim of reducing
the bleeding. Both cooling and re-
warming phases were done with the
MECC. Some minutes before the start
of arrest (body temperature 20C), the
activated clotting time (ACT) was in-
creased to 480 seconds, and the blood
was drained from a different cardiot-
omy added to the circuit. We observed
that blood loss and hemostasis were
easy to manage in both patients with
2 large surgical incisions, in the chest
and abdomen. Both patients were dis-
charged alive.
Maintaining the ACT around 200 to
300 seconds during the MECC proce-
dure is one of the keys of the system.
We have usually used the same ACT
target reported by Puehler and col-
leagues, which is similar to the ACT
of our patients operated on off-pump234 The Journal of Thoracic and Cand is statistically lower than that our
patients operated on with ECC. More-
over, in an ongoing prospective ran-
domized trial, we found that patients
operated on with standard ECC had
more postoperative bleeding and
need for more red blood cell transfu-
sions than did those in MECC and
off-pump CABG groups.
The concept of a miniaturized sys-
tem means less biologic and metabolic
invasiveness, or in other words, as
Puehler and colleagues intend, less
hemodilution, better renal and pulmo-
nary preservation, less coagulative
disorder, and less inflammatory re-
sponse. Last but not least, in an era in
which coronary surgery on high-risk
patients is increasing and many sur-
geons are afraid to use standard ECC,
complete myocardial revasculariza-
tion with the MECC could be a valid
option to achieve good clinical out-
come.
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Cardiac Surgery Clinic
San Gerardo Hospital, Monza,
University of Milano-Bicocca,
ItalyReferences
1. Formica F, Broccolo F, Martino A, Sciucchetti J,
Giordano V, Avalli L, et al. Myocardial revascular-
ization with miniaturized extracorporeal circulation
versus off pump: Evaluation of systemic and myo-
cardial inflammatory response in a prospective ran-
domized study. J Thorac Cardiovasc Surg. 2009;
137:1206-12.
2. Puehler T, Haneya A, Philipp A, Wiebe K,
Keyser A, Rupprecht L, et al. Minimal extracorpo-
real circulation: an alternative for on-pump and
off-pump coronary revascularization. Ann Thorac
Surg. 2009;87:766-72.
3. Mizutani S, Matsuura A, Miyahara K, Eda T,
Kawamura A, Yoshioka T, et al. On-pump beat-
ing-heart coronary artery bypass: a propensity
matched analysis. Ann Thorac Surg. 2007;83:
1368-73.
4. Williams ML, Muhlbaier LH, Schroder JN,
Hata JA, Peterson ED, Smith PK, et al. Risk-ad-
justed short- and long-term outcomes for on-pump
versus off-pump coronary artery bypass surgery.
Circulation. 2005;112:I366-70.
5. Chu D, Bakaeen FG, Dao TK, Lemaire SA,
Coselli JS, Huh J. On-pump versus off-pump coro-
nary artery bypass grafting in a cohort of 63,000 pa-
tients. Ann Thorac Surg. 2009;87:1820-6.
doi:10.1016/j.jtcvs.2009.09.008ardiovascular Surgery c January 2009LUNG VENTILATION/
PERFUSION MAY REDUCE
PULMONARY INJURY DURING
CARDIOPULMONARY BYPASS
To the Editor:
During cardiac surgery with cardio-
pulmonary bypass (CPB), the surgeon
is assured that all organs are perfused
and/or protected. The heart—lung ma-
chine provides perfusion to all organs
while the heart is either cardioplegically
arrested or perfused.1 One assumes that
the lungs are perfused, although pulmo-
nary artery blood flow, themajor source
of blood supply to the lungs, ceases.
Discontinuation of pulsatile flow and
low mean pressures further accentuate
decreased bronchial artery flow. The
lung is the ‘‘target’’ organ, especially
during prolonged CPB. Severe pulmo-
nary dysfunction, manifested as poor
gas exchange, pulmonary edema, and
prolonged need for artificial ventilation,
are consequences.
Imura and associates2 correlated
low-frequency mechanical ventilation
during CPB in pigs with suppression
of ischemic derangements in tissue
metabolism and histopathologic
changes in the lungs. The technique
appears simple and safe and could po-
tentially be used in clinical practice.2
Why have cardiac surgeons not per-
fused/ventilated the lungs during
CPB? Should they? The majority of
surgeons were not trained in lung per-
fusion and most would say that, for
short pump runs, the results are excel-
lent. Perfusion of the lungs leads to
blood in the operative field and
decreases surgical precision. Lung
perfusion does not necessarily have
to be continuous. Intermittent lung
perfusion (pneumoplegia) could be
instituted at the same time that the
surgeon administers intermittent cold
cardioplegic arrest. This would elimi-
nate the problem of visualization and
blood in the operative field. A compro-
mise, as suggested by Imura and asso-
ciates,2 is simply to ventilate the lungs
in the hope that some gas exchange
wouldoccur.Low-frequencyventilation2
